Will we see protection or reinfection in COVID-19?
作者信息
Ota Miyo
机构信息
Sinai Immunology Review Project, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
出版信息
Nat Rev Immunol. 2020 Jun;20(6):351. doi: 10.1038/s41577-020-0316-3.
Abstract
摘要
相似文献
1
Will we see protection or reinfection in COVID-19?在新冠病毒感染中，我们会看到（病毒）防护还是再感染的情况呢？
Nat Rev Immunol. 2020 Jun;20(6):351. doi: 10.1038/s41577-020-0316-3.
2
Case Report: A Recovered SARS CoV-2 Patient Protected From Reinfection.病例报告：一名康复的新冠病毒患者对再次感染具有免疫力。
Front Med (Lausanne). 2020 Sep 25;7:564264. doi: 10.3389/fmed.2020.564264. eCollection 2020.
3
Is novel coronavirus 2019 reinfection possible? Interpreting dynamic SARS-CoV-2 test results.新型冠状病毒 2019 年是否可能再次感染？解读动态 SARS-CoV-2 检测结果。
Am J Emerg Med. 2021 Jan;39:256.e1-256.e3. doi: 10.1016/j.ajem.2020.06.079. Epub 2020 Jul 4.
4
CD8+ T Cells Can Mediate Short-Term Protection against Heterotypic Dengue Virus Reinfection in Mice.CD8 + T细胞可介导小鼠对异型登革病毒再感染的短期保护。
J Virol. 2015 Jun;89(12):6494-505. doi: 10.1128/JVI.00036-15. Epub 2015 Apr 8.
5
COVID-19 reinfection? A suspected case in a Peruvian patient.新冠病毒再次感染？秘鲁一名患者的疑似病例。
Travel Med Infect Dis. 2021 Jan-Feb;39:101947. doi: 10.1016/j.tmaid.2020.101947. Epub 2020 Dec 8.
6
COVID-19 in a patient with end-stage renal disease on chronic in-center hemodialysis after evidence of SARS-CoV-2 IgG antibodies. Reinfection or inaccuracy of antibody testing.在一名接受慢性中心血液透析的终末期肾病患者中，出现严重急性呼吸综合征冠状病毒2（SARS-CoV-2）IgG抗体后感染了2019冠状病毒病。抗体检测存在再次感染或不准确的情况。
IDCases. 2020;22:e00943. doi: 10.1016/j.idcr.2020.e00943. Epub 2020 Sep 6.
7
Severe, Symptomatic Reinfection in a Patient with COVID-19.一名新冠肺炎患者发生严重的有症状再感染
R I Med J (2013). 2020 Nov 9;103(10):24-26.
8
Estimation of the Probability of Reinfection With COVID-19 by the Susceptible-Exposed-Infectious-Removed-Undetectable-Susceptible Model.应用易感-暴露-感染-移除-不可检出-易感模型估计 COVID-19 再感染的概率。
JMIR Public Health Surveill. 2020 May 13;6(2):e19097. doi: 10.2196/19097.
9
Reinfection with SARS-CoV-2: Discrete SIR (Susceptible, Infected, Recovered) Modeling Using Empirical Infection Data.SARS-CoV-2 再感染：使用经验感染数据的离散 SIR（易感、感染、恢复）建模。
JMIR Public Health Surveill. 2020 Nov 16;6(4):e21168. doi: 10.2196/21168.
10
Relationships among dissemination of primary parainfluenza virus infection in the respiratory tract, mucosal and peripheral immune responses, and protection from reinfection: a noninvasive bioluminescence-imaging study.原发性副流感病毒感染在呼吸道中的传播、黏膜和外周免疫反应以及预防再感染之间的关系：一项非侵入性生物发光成像研究。
J Virol. 2015 Apr;89(7):3568-83. doi: 10.1128/JVI.03581-14. Epub 2015 Jan 14.
引用本文的文献
1
Lateral Flow Immunoassays for SARS-CoV-2.用于检测新型冠状病毒的侧向流动免疫分析方法。
Diagnostics (Basel). 2022 Nov 18;12(11):2854. doi: 10.3390/diagnostics12112854.
2
Clinical and epidemiological features of patients with COVID-19 reinfection: a systematic review.新冠病毒二次感染患者的临床和流行病学特征：一项系统综述
New Microbes New Infect. 2022 Jul;48:101021. doi: 10.1016/j.nmni.2022.101021. Epub 2022 Aug 28.
3
An Update on Protective Effectiveness of Immune Responses After Recovery From COVID-19.关于从 COVID-19 中康复后免疫反应的保护效力的最新进展。
Front Immunol. 2022 May 20;13:884879. doi: 10.3389/fimmu.2022.884879. eCollection 2022.
4
Long-term persistence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike protein-specific and neutralizing antibodies in recovered COVID-19 patients.康复的 COVID-19 患者中严重急性呼吸综合征冠状病毒 2（SARS-CoV-2）刺突蛋白特异性和中和抗体的长期持久性。
PLoS One. 2022 Apr 21;17(4):e0267102. doi: 10.1371/journal.pone.0267102. eCollection 2022.
5
Current status, advances, challenges and perspectives on biosensors for COVID-19 diagnosis in resource-limited settings.资源有限环境下用于新冠病毒诊断的生物传感器的现状、进展、挑战及展望
Sens Actuators Rep. 2021 Nov;3:100025. doi: 10.1016/j.snr.2021.100025. Epub 2021 Jan 7.
6
A systematic review on SARS-CoV-2 remission: an emerging challenge for its management, treatment, immunization strategies, and post-treatment guidelines.关于严重急性呼吸综合征冠状病毒2型缓解的系统评价：对其管理、治疗、免疫策略和治疗后指南的新挑战。
New Microbes New Infect. 2022 Jan;45:100949. doi: 10.1016/j.nmni.2022.100949. Epub 2022 Jan 7.
7
Clinical predictive risk factors prolonged the duration of SARS-CoV-2 clearance in 279 moderate COVID-19 patients: A multicenter retrospective cohort study.临床预测风险因素延长了 279 例中度 COVID-19 患者 SARS-CoV-2 清除时间：一项多中心回顾性队列研究。
Medicine (Baltimore). 2021 Oct 8;100(40):e27410. doi: 10.1097/MD.0000000000027410.
8
Two-Step In Vitro Model to Evaluate the Cellular Immune Response to SARS-CoV-2.两步体外模型评估对 SARS-CoV-2 的细胞免疫反应。
Cells. 2021 Aug 26;10(9):2206. doi: 10.3390/cells10092206.
9
A review of mathematical model-based scenario analysis and interventions for COVID-19.基于数学模型的 COVID-19 情景分析和干预措施综述。
Comput Methods Programs Biomed. 2021 Sep;209:106301. doi: 10.1016/j.cmpb.2021.106301. Epub 2021 Jul 27.
10
From Isolation to Containment: Perceived Fear of Infectivity and Protective Behavioral Changes during the COVID-19 Vaccination Campaign.从隔离到遏制：新冠疫苗接种运动期间对感染性的感知恐惧及防护行为变化
Int J Environ Res Public Health. 2021 Jun 16;18(12):6503. doi: 10.3390/ijerph18126503.
Zotero 插件